Cargando…

Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes

BACKGROUND: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhiyuan, Yu, Siqi, Zhang, Haiping, Guo, Zheng, Zheng, Yulu, Xu, Zongkai, Li, Zhiwei, Liu, Xiangtong, Li, Xia, Chen, Shuo, Zhang, Jingbo, Tao, Lixin, Guo, Xiuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706858/
https://www.ncbi.nlm.nih.gov/pubmed/36443820
http://dx.doi.org/10.1186/s12933-022-01696-1
_version_ 1784840588306153472
author Wu, Zhiyuan
Yu, Siqi
Zhang, Haiping
Guo, Zheng
Zheng, Yulu
Xu, Zongkai
Li, Zhiwei
Liu, Xiangtong
Li, Xia
Chen, Shuo
Zhang, Jingbo
Tao, Lixin
Guo, Xiuhua
author_facet Wu, Zhiyuan
Yu, Siqi
Zhang, Haiping
Guo, Zheng
Zheng, Yulu
Xu, Zongkai
Li, Zhiwei
Liu, Xiangtong
Li, Xia
Chen, Shuo
Zhang, Jingbo
Tao, Lixin
Guo, Xiuhua
author_sort Wu, Zhiyuan
collection PubMed
description BACKGROUND: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascular complication. METHODS: A total of 1870 patients of diabetes were enrolled from Beijing Health Management Cohort between 2008 and 2018 as baseline, and then followed for macrovascular complication onset. We proposed a composite risk score (0–4) by arterial stiffness severity, pool glycemic control and hypertension status. Cox model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: The mean age (SD) of this population was 59.90 (12.29) years. During a median follow-up of 4.0 years, 359 (19.2%) patients developed macrovascular complication. Compared to the normal arterial stiffness and good glycemic control group, patients with severe arterial stiffness and pool glycemic control had the highest risk of macrovascular complications (HR: 2.73; 95% CI: 1.42–5.25). Similarly, those of severe arterial stiffness and hypertension had the highest risk (HR: 2.69; 95% CI: 1.61–4.50). Patients of the composite score > 2 had a significantly increased risk of macrovascular complication. CONCLUSION: This study suggested the clinical importance of combined evaluation of arterial stiffness, glycemic control and hypertension status for the risk stratification and management of macrovascular complication of type 2 diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01696-1.
format Online
Article
Text
id pubmed-9706858
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97068582022-11-30 Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes Wu, Zhiyuan Yu, Siqi Zhang, Haiping Guo, Zheng Zheng, Yulu Xu, Zongkai Li, Zhiwei Liu, Xiangtong Li, Xia Chen, Shuo Zhang, Jingbo Tao, Lixin Guo, Xiuhua Cardiovasc Diabetol Research BACKGROUND: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascular complication. METHODS: A total of 1870 patients of diabetes were enrolled from Beijing Health Management Cohort between 2008 and 2018 as baseline, and then followed for macrovascular complication onset. We proposed a composite risk score (0–4) by arterial stiffness severity, pool glycemic control and hypertension status. Cox model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: The mean age (SD) of this population was 59.90 (12.29) years. During a median follow-up of 4.0 years, 359 (19.2%) patients developed macrovascular complication. Compared to the normal arterial stiffness and good glycemic control group, patients with severe arterial stiffness and pool glycemic control had the highest risk of macrovascular complications (HR: 2.73; 95% CI: 1.42–5.25). Similarly, those of severe arterial stiffness and hypertension had the highest risk (HR: 2.69; 95% CI: 1.61–4.50). Patients of the composite score > 2 had a significantly increased risk of macrovascular complication. CONCLUSION: This study suggested the clinical importance of combined evaluation of arterial stiffness, glycemic control and hypertension status for the risk stratification and management of macrovascular complication of type 2 diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01696-1. BioMed Central 2022-11-28 /pmc/articles/PMC9706858/ /pubmed/36443820 http://dx.doi.org/10.1186/s12933-022-01696-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wu, Zhiyuan
Yu, Siqi
Zhang, Haiping
Guo, Zheng
Zheng, Yulu
Xu, Zongkai
Li, Zhiwei
Liu, Xiangtong
Li, Xia
Chen, Shuo
Zhang, Jingbo
Tao, Lixin
Guo, Xiuhua
Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
title Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
title_full Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
title_fullStr Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
title_full_unstemmed Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
title_short Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
title_sort combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706858/
https://www.ncbi.nlm.nih.gov/pubmed/36443820
http://dx.doi.org/10.1186/s12933-022-01696-1
work_keys_str_mv AT wuzhiyuan combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT yusiqi combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT zhanghaiping combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT guozheng combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT zhengyulu combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT xuzongkai combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT lizhiwei combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT liuxiangtong combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT lixia combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT chenshuo combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT zhangjingbo combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT taolixin combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes
AT guoxiuhua combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes